NCT05691764View on ClinicalTrials.gov

Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

September 1, 2022

Conditions
Myocardial InjuryCardiac Surgery
Interventions
DRUG

Cyclosporin

Cyclosporin was administered intravenously with the dose of 3 mg/ kg body weight

PROCEDURE

remote ischemic preconditioning

Performed by inflating pressure cuff on the extremity 30 mmHg higher than systolic blood pressure of the patient for 5x5 minutes with 5 minutes reperfusion interval

DRUG

Placebo

Intravenous placebo

Trial Locations (1)

10430

Indonesia University, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05691764 - Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery | Biotech Hunter | Biotech Hunter